Ibogaine is a naturally occurring indole alkaloid extracted primarily from the root bark of Tabernanthe iboga, a rainforest shrub native to Central West Africa. It is a psychoactive, long-acting compound often described as a psychedelic, although its effects and pharmacology are broader than that shorthand suggests.
For a concise consumer-oriented overview, Bicycle Health’s explanation of ibogaine places it in the context of opioid-use questions while stressing that investigation is not the same as approved care. The basic point is simple: ibogaine may alter withdrawal, cravings, perception, and mood, but it also creates substantial safety uncertainty.
People sometimes use “ibogaine treatment” to mean very different things: traditional iboga use, an overseas clinic, a research setting, or discussion of related compounds. That distinction matters because the legal status, dosage, source material, medical supervision, and level of safety screening can be very different.
Where does ibogaine come from?
Tabernanthe iboga grows in Central West Africa, especially in Gabon and nearby Cameroon. In the Bwiti spiritual tradition, iboga root bark has been used ceremonially for centuries in community rites of passage and healing rituals. Bwiti practice is not interchangeable with a medical protocol or with a commercial clinic model.
Whole iboga root bark contains at least a dozen distinct alkaloids. By contrast, pharmaceutical-style ibogaine usually refers to one isolated alkaloid, often an ibogaine hydrochloride salt. The difference affects what someone means by a total alkaloid preparation, an iboga extract, or a single-compound product.
Dictionary definitions can be useful for a first pass, including the definition of ibogaine, but a definition alone cannot explain the risks attached to a psychoactive compound that acts across multiple body systems.